青蒿琥酯联合蒿甲醚治疗耐药恶性疟疾患者疗效观察

doi:10.3969/j.issn.1672-5069.2014.06.026

Abstract

Duan Wenbin, Yan Zhigang, Duan Huichun. Efficacy of artesunate in treatment of patients with malaria[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 655-657.

[1] Kim JH,Choi AR,Kim YK,et al. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing Pgp inhibition. Biochem Biophys Res Commun,2013,441（3）:655-660.
[2] Abolaji AO,Osedeme F,Olusemire O. Artesunate-amodiaquine combination therapy in the absence of malarial parasite infection induces oxidative damage in female rats. Cell Biochem Funct, 2013,12（3）:1002-1007.
[3] Chung MK,Yu WJ,Lee JS,et al. Embryotoxicity and toxicokinetics of the antimalarial artesunate in rats. Toxicol Res,2013,29（1）:27-34.
[4] Zakai HA,Khan W,Asma U. Prevalence of mutation and phenotypic expression associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum and Plasmodium vivax. Folia Parasitol （Praha）,2013,60（4）:372-376.
[5] Gosi P,Lanteri CA,Tyner SD,et al. Evaluation of parasite subpopulations and genetic diversity of the msp1,msp2 and glurp genes during and following artesunate monotherapy treatment of plasmodium falciparum malaria in western Cambodia. Malar J,2013,12（1）:403.
[6] Schleiferbock S,Scheurer C,Ihara M,et al. In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models. Drug Des Devel Ther,2013,15（7）:1377-1384.
[7] Le Manach C,Scheurer C,Sax S,et al. Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum. Malar J,2013,12（1）:424.
[8] Miranda AS,Brant F,Rocha NP,et al. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria. Malar J,2013,12（1）:388.
[9] Khattak AA,Venkatesan M,Jacob CG,et al.A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan. Malar J,2013,12（1）:300. [10] Ojurongbe O,Lawal OA,Abiodun OO,et al.Efficacy of artemisinin combination therapy for the treatment of uncomplicated falciparum malaria in Nigerian children. J Infect Dev Ctries,2013,7（12）:975-982.
[11] Iribhogbe OI,Agbaje EO,Oreagba IA,et al. Oxidative stress and micronutrient therapy in malaria:an in vivo study in Plasmodium berghei infected mice. Pak J Biol Sci,2013,16（4）:160-167.
[12] Wu C,Liu J,Pan X,et al. Design,synthesis and evaluation of the antibacterial enhancement activities of amino dihydroartemisinin derivatives. Molecules,2013,18（6）:6866-6882.
[13] Olupot-Olupot P,Maitland K. Management of severe malaria: results from recent trials. Adv Exp Med Biol,2013,764:241-250. [14] Lopera-Mesa TM,Doumbia S,Chiang S,et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria:effect of acquired immunity. J Infect Dis,2013,207（11）:1655-1663.
[15] Mishra N,Singh JP,Srivastava B,et al. Monitoring antimalarial drug resistance in India via sentinel sites:outcomes and risk factors for treatment failure,2009-2010. Bull World Health Organ,2012,90（12）:895-904.

Efficacy of artesunate in treatment of patients with malaria

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.